Influence of Pelacarsen on Arterial Wall Properties and Risk Factors in Patients After Myocardial Infarction With High Lp(a) Values
Latest Information Update: 10 Jan 2022
Price :
$35 *
At a glance
- Drugs Pelacarsen (Primary)
- Indications Hyperlipoproteinaemia
- Focus Pharmacokinetics; Therapeutic Use
- Acronyms PEMILA
- 10 Dec 2021 Status changed from not yet recruiting to withdrawn prior to enrolment.(The study was stopped due to Administrative reason).
- 13 Aug 2021 New trial record